Clinical assessment of chemotherapy-induced peripheral neuropathy: a discrete choice experiment of patient preferences

Patient factors associated with discrepancies between patient-reported and clinician-documented peripheral neuropathy in women with breast cancer receiving paclitaxel: a pilot study

(2020) Teresa M. Salgado et al.   BREAST

Characterizing patient-clinician chemotherapy-induced peripheral neuropathy assessment and management communication approaches

(2019) Robert Knoerl et al.   PATIENT EDUCATION AND COUNSELING

Discrete Choice Experiments in Health Economics: Past, Present and Future

(2018) Vikas Soekhai et al.   PHARMACOECONOMICS

Falls, Functioning, and Disability Among Women With Persistent Symptoms of Chemotherapy-Induced Peripheral Neuropathy

(2017) Kerri M. Winters-Stone et al.   JOURNAL OF CLINICAL ONCOLOGY

Multinomial Logit Models with Continuous and Discrete Individual Heterogeneity in R: The gmnl Package

(2017) Mauricio Sarrias et al.   Journal of Statistical Software

Long-term Peripheral Neuropathy in Breast Cancer Patients Treated With Adjuvant Chemotherapy: NRG Oncology/NSABP B-30

(2017) Hanna Bandos et al.   JNCI-Journal of the National Cancer Institute

Optimal clinical assessment strategies for chemotherapy-induced peripheral neuropathy (CIPN): a systematic review and Delphi survey

(2017) J . Matt McCrary et al.   SUPPORTIVE CARE IN CANCER

A discrete choice experiment to assess cancer patients’ preferences for when and how to make treatment decisions

(2017) Anne Herrmann et al.   SUPPORTIVE CARE IN CANCER

Long-term Peripheral Neuropathy in Breast Cancer Patients Treated With Adjuvant Chemotherapy: NRG Oncology/NSABP B-30

(2017) Hanna Bandos et al.   JNCI-Journal of the National Cancer Institute

Long-Term Effects, Pathophysiological Mechanisms, and Risk Factors of Chemotherapy-Induced Peripheral Neuropathies: A Comprehensive Literature Review

(2017) Nicolas Kerckhove et al.   Frontiers in Pharmacology

Long-term chemotherapy-induced peripheral neuropathy among breast cancer survivors: prevalence, risk factors, and fall risk

(2016) Ting Bao et al.   BREAST CANCER RESEARCH AND TREATMENT

The Association of Chemotherapy-Induced Peripheral Neuropathy Symptoms and the Risk of Falling

(2016) Noah A. Kolb et al.   JAMA Neurology

Physician-assessed and patient-reported outcome measures in chemotherapy-induced sensory peripheral neurotoxicity: two sides of the same coin

(2013) P. Alberti et al.   ANNALS OF ONCOLOGY

Chemotherapy-induced peripheral neurotoxicity: A critical analysis

(2013) Susanna B. Park et al.   CA-A CANCER JOURNAL FOR CLINICIANS

Chemotherapy-induced peripheral neurotoxicity (CIPN): An update

(2011) Andreas A. Argyriou et al.   CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY

Feasibility and validity of the Patient Neurotoxicity Questionnaire during taxane chemotherapy in a phase III randomized trial in patients with breast cancer: N-SAS BC 02

(2009) Kojiro Shimozuma et al.   SUPPORTIVE CARE IN CANCER